Resistance Training to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease
A Novel Individualized Resistance Training Program to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
25
1 country
1
Brief Summary
Structural changes in skeletal muscles of patients with chronic obstructive pulmonary disease (COPD) have been linked to impaired muscle function, reduced exercise capacity, and increased mortality associated with this disease. Muscle dysfunction also contributes to dyspnea intensity and the ability to sustain exercise, making aerobic exercise training intolerable at the intensity and/or volume required to achieve clinically important changes. Resistance training (RT) is an attractive exercise modality because it is efficacious and more tolerable initially. No work has examined whether a short-term RT program can reduce exertional symptoms and improve exercise tolerance (dyspnea and leg fatigue) in patients with COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease
Started Aug 2016
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 5, 2016
CompletedFirst Posted
Study publicly available on registry
August 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedJune 13, 2022
June 1, 2022
3.5 years
August 5, 2016
June 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dyspnea
The change in the sensory intensity of dyspnea measured at an iso-time during the constant load exercise trials post RT
Baseline and post 4 weeks (12 sessions) of resistance training
Secondary Outcomes (4)
Exercise Tolerance
Baseline and post 4 weeks (12 sessions) of resistance training
Secondary Dyspnea Outcomes
Baseline and post 4 weeks (12 sessions) of resistance training
Quadriceps Fatigue
Baseline and post 4 weeks (12 sessions) of resistance training
Muscle Strength and Endurance
Baseline and post 4 weeks (12 sessions) of resistance training
Study Arms (1)
Resistance training
EXPERIMENTALPatients with COPD will participate in 4 weeks (12 sessions) of individualized, non-linear, lower body resistance training.
Interventions
Lower body resistance exercises will be prescribed in various combinations over multiple days and individually modified and progressed to achieve advances in both movement pattern, intensity, and exercise volume.
Eligibility Criteria
You may qualify if:
- Non-smokers \>6 months
- FEV1/FVC \<0.7 and lower limit of normal
- %\< FEV1 pred \<70%
- Stable (no exacerbation for \>3 months)
You may not qualify if:
- Cardiovascular and cerebrovascular disease
- Diabetes
- Cardiovascular contraindications to exercise
- Uncontrolled hypertension
- Currently performing regular structured exercise \>3x/week for 30 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia
Kelowna, British Columbia, V1V 1V7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil Eves, PhD
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 5, 2016
First Posted
August 9, 2016
Study Start
August 1, 2016
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
June 13, 2022
Record last verified: 2022-06